Status
Conditions
Treatments
About
This is a single-site, prospective, clinical study of subjects that are scheduled to undergo either total hip or total knee arthroplasties. It is anticipated that surgical wounds treated with SurgX will exhibit reduced surgical site complication rates and improved post-operative treatment outcomes by potentially decreasing site bioburden of both free-floating and biofilm-entrenched organisms.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
700 participants in 2 patient groups
Loading...
Central trial contact
Meriton Ruhani; Evangelia Zgonis
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal